Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Indole-based inhibitors of angiogenesis designed at Abbott

Jan. 15, 2002

4SC and Wilex enter research collaboration for second-generation uPA inhibitors

Jan. 15, 2002

INGN-251 endowed with both cell-killing and antimetastatic properties according to recent data

Jan. 15, 2002

INGN-201 does not integrate into the host cell genome, demonstrates activity as anticancer vaccine

Jan. 15, 2002

Oncolytic viruses from Cell Genesys show potential in combination therapy of tumors

Jan. 14, 2002

IND for satraplatin transferred to NeoOncoRx

Jan. 14, 2002

Chiron obtains option to Procyon prostate cancer technology

Jan. 14, 2002

Patent coverage obtained by NeoPharm for a NeoLipid antisense compound

Jan. 14, 2002

FDA advisory committee delays review of Bexxar

Jan. 14, 2002

Genta files IND for gallium nitrate in NHL

Jan. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...